231 related articles for article (PubMed ID: 36090994)
41. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma.
Zhu X; Heng Y; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
Hum Cell; 2024 May; 37(3):714-728. PubMed ID: 38358636
[TBL] [Abstract][Full Text] [Related]
43. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.
Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U
Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287
[TBL] [Abstract][Full Text] [Related]
44. Expression of
Zhang P; Zhao Y; Xia X; Mei S; Huang Y; Zhu Y; Yu S; Chen X
Oncoimmunology; 2023; 12(1):2203073. PubMed ID: 37089448
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Analysis of the Role of
Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C
Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875
[TBL] [Abstract][Full Text] [Related]
46. Identification of a ferroptosis-associated gene signature and the related therapeutic targets in head and neck squamous carcinoma.
Huang Z; Li Y; Hong W; Chen X; Pan Y; Weng Y; Liu W; Wang L; Qiu S
Int Immunopharmacol; 2022 Jan; 102():108431. PubMed ID: 34906855
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma.
Kawakita D; Oze I; Hosono S; Ito H; Watanabe M; Yatabe Y; Hasegawa Y; Murakami S; Tanaka H; Matsuo K
J Epidemiol; 2016 Jun; 26(6):292-9. PubMed ID: 26804037
[TBL] [Abstract][Full Text] [Related]
48. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
49. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
50. Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Lee DJ; Lee HM; Kim JH; Park IS; Rho YS
World J Surg Oncol; 2017 Aug; 15(1):163. PubMed ID: 28841898
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
52. Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma.
Deng H; Wei Z; Qiu S; Ye D; Gu S; Shen Y; Shen Z; Jin Y; Zhou C
J Clin Lab Anal; 2022 Apr; 36(4):e24292. PubMed ID: 35156730
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Xiong Y; Si Y; Feng Y; Zhuo S; Cui B; Zhang Z
Immun Inflamm Dis; 2021 Mar; 9(1):196-209. PubMed ID: 33277966
[TBL] [Abstract][Full Text] [Related]
54. FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis.
Chen Y; Liu Y; Ni H; Ding C; Zhang X; Zhang Z
Int J Oncol; 2017 Oct; 51(4):1045-1054. PubMed ID: 28848994
[TBL] [Abstract][Full Text] [Related]
55. Immune gene expression in head and neck squamous cell carcinoma patients.
Lecerf C; Kamal M; Vacher S; Chemlali W; Schnitzler A; Morel C; Dubot C; Jeannot E; Meseure D; Klijanienko J; Mariani O; Borcoman E; Calugaru V; Badois N; Chilles A; Lesnik M; Krhili S; Choussy O; Hoffmann C; Piaggio E; Bieche I; Le Tourneau C
Eur J Cancer; 2019 Nov; 121():210-223. PubMed ID: 31593831
[TBL] [Abstract][Full Text] [Related]
56. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
[TBL] [Abstract][Full Text] [Related]
57. Low expression of AIM2 combined with high expression of p‑STAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
Li Z; Shi X; Li H; Wang W; Li X
Oncol Rep; 2019 Apr; 41(4):2396-2408. PubMed ID: 30816544
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
59. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
Zhang S; Yu S; Wang J; Cheng Z
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
[TBL] [Abstract][Full Text] [Related]
60. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
